Pharma giant GSK just made a $5.1 billion bet on a cancer drugmaker


GlaxoSmithKline just agreed to acquire the cancer drugmaker Tesaro for $5.1 billion in a bid to bulk up its cancer pipeline. GSK has been working to refresh its research-and-development strategy - in July it made a $300 million investment in the consumer-genetics company 23andMe.



from Biotech News